ID   ZYX_HUMAN               Reviewed;         572 AA.
AC   Q15942; A4D2G6; Q6I9S4;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 1.
DT   14-MAY-2014, entry version 138.
DE   RecName: Full=Zyxin;
DE   AltName: Full=Zyxin-2;
GN   Name=ZYX;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Umbilical vein;
RX   PubMed=8940160; DOI=10.1074/jbc.271.49.31470;
RA   Macalma T., Otte J., Hensler M.E., Bockholt S.M., Louis H.A.,
RA   Kalff-Suske M., Grzeschik K.H., von der Ahe D., Beckerle M.C.;
RT   "Molecular characterization of human zyxin.";
RL   J. Biol. Chem. 271:31470-31478(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Placenta;
RX   PubMed=8917469; DOI=10.1111/j.1432-1033.1996.00657.x;
RA   Zumbrunn J., Trueb B.;
RT   "A zyxin-related protein whose synthesis is reduced in virally
RT   transformed fibroblasts.";
RL   Eur. J. Biochem. 241:657-663(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z.,
RA   Lu F., Zeesman S., Nowaczyk M.J., Teshima I., Chitayat D., Shuman C.,
RA   Weksberg R., Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J.,
RA   Rahman N., Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F.,
RA   Belloni E., Shaffer L.G., Pober B., Morton C.C., Gusella J.F.,
RA   Bruns G.A.P., Korf B.R., Quade B.J., Ligon A.H., Ferguson H.,
RA   Higgins A.W., Leach N.T., Herrick S.R., Lemyre E., Farra C.G.,
RA   Kim H.-G., Summers A.M., Gripp K.W., Roberts W., Szatmari P.,
RA   Winsor E.J.T., Grzeschik K.-H., Teebi A., Minassian B.A., Kere J.,
RA   Armengol L., Pujana M.A., Estivill X., Wilson M.D., Koop B.F.,
RA   Tosi S., Moore G.E., Boright A.P., Zlotorynski E., Kerem B.,
RA   Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W.,
RA   Mural R.J., Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Kidney, Skin, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PROTEIN SEQUENCE OF 2-25; 36-54; 168-184; 280-320 AND 325-375,
RP   CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT ALA-2, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RA   Bienvenut W.V., Calvo F.;
RL   Submitted (FEB-2008) to UniProtKB.
RN   [8]
RP   INTERACTION WITH ENAH AND VASP, AND MUTAGENESIS OF PHE-71; PHE-93;
RP   PHE-104 AND PHE-114.
RX   PubMed=10801818; DOI=10.1074/jbc.M001698200;
RA   Drees B., Friederich E., Fradelizi J., Louvard D., Beckerle M.C.,
RA   Golsteyn R.M.;
RT   "Characterization of the interaction between zyxin and members of the
RT   Ena/vasodilator-stimulated phosphoprotein family of proteins.";
RL   J. Biol. Chem. 275:22503-22511(2000).
RN   [9]
RP   INTERACTION WITH HPV6 E6.
RX   PubMed=11689660; DOI=10.1128/JVI.75.23.11791-11802.2001;
RA   Degenhardt Y.Y., Silverstein S.;
RT   "Interaction of zyxin, a focal adhesion protein, with the E6 protein
RT   from human papillomavirus type 6 results in its nuclear
RT   translocation.";
RL   J. Virol. 75:11791-11802(2001).
RN   [10]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH TES.
RX   PubMed=12695497; DOI=10.1083/jcb.200211015;
RA   Garvalov B.K., Higgins T.E., Sutherland J.D., Zettl M., Scaplehorn N.,
RA   Koecher T., Piddini E., Griffiths G., Way M.;
RT   "The conformational state of Tes regulates its zyxin-dependent
RT   recruitment to focal adhesions.";
RL   J. Cell Biol. 161:33-39(2003).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-344, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-259 AND SER-281, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17924679; DOI=10.1021/pr070152u;
RA   Yu L.R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
RT   "Improved titanium dioxide enrichment of phosphopeptides from HeLa
RT   cells and high confident phosphopeptide identification by cross-
RT   validation of MS/MS and MS/MS/MS spectra.";
RL   J. Proteome Res. 6:4150-4162(2007).
RN   [14]
RP   INTERACTION WITH EVL; VASP AND ENAH.
RX   PubMed=18158903; DOI=10.1016/j.molcel.2007.10.033;
RA   Boeda B., Briggs D.C., Higgins T., Garvalov B.K., Fadden A.J.,
RA   McDonald N.Q., Way M.;
RT   "Tes, a specific Mena interacting partner, breaks the rules for EVH1
RT   binding.";
RL   Mol. Cell 28:1071-1082(2007).
RN   [15]
RP   SUBCELLULAR LOCATION.
RX   PubMed=18297730; DOI=10.1002/dvdy.21471;
RA   Martynova N.Y., Eroshkin F.M., Ermolina L.V., Ermakova G.V.,
RA   Korotaeva A.L., Smurova K.M., Gyoeva F.K., Zaraisky A.G.;
RT   "The LIM-domain protein zyxin binds the homeodomain factor Xanf1/Hesx1
RT   and modulates its activity in the anterior neural plate of Xenopus
RT   laevis embryo.";
RL   Dev. Dyn. 237:736-749(2008).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-267; SER-281 AND
RP   SER-344, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-169; SER-259; SER-267;
RP   THR-270; THR-274; SER-281; SER-288; SER-308 AND SER-344, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [19]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [21]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-279, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-169; THR-179; SER-259;
RP   THR-274; SER-281; SER-308 AND SER-344, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [23]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-267; THR-270; SER-281
RP   AND SER-344, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [25]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
CC   -!- FUNCTION: Adhesion plaque protein. Binds alpha-actinin and the CRP
CC       protein. Important for targeting TES and ENA/VASP family members
CC       to focal adhesions and for the formation of actin-rich structures.
CC       May be a component of a signal transduction pathway that mediates
CC       adhesion-stimulated changes in gene expression (By similarity).
CC   -!- SUBUNIT: Interacts with HPV type 6 protein E6. Does not interact
CC       significantly with E6 proteins from HPV types 11, 16, or 18.
CC       Interacts, via the Pro-rich regions, with the EVH1 domains of
CC       ENAH, EVL and VASP. Interacts with the first LIM domain of TES.
CC       Interacts with NEBL (isoform 2).
CC   -!- INTERACTION:
CC       Q14847:LASP1; NbExp=5; IntAct=EBI-444225, EBI-742828;
CC       O95835:LATS1; NbExp=10; IntAct=EBI-444225, EBI-444209;
CC       P35372:OPRM1; NbExp=2; IntAct=EBI-444225, EBI-2624570;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Cytoplasm, cytoskeleton. Nucleus.
CC       Cell junction, focal adhesion. Note=Associates with the actin
CC       cytoskeleton near the adhesion plaques. Enters the nucleus in the
CC       presence of HESX1.
CC   -!- SIMILARITY: Belongs to the zyxin/ajuba family.
CC   -!- SIMILARITY: Contains 3 LIM zinc-binding domains.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X94991; CAA64447.1; -; mRNA.
DR   EMBL; X95735; CAA65050.1; -; mRNA.
DR   EMBL; CR457431; CAG33712.1; -; mRNA.
DR   EMBL; AC092214; AAS07459.1; -; Genomic_DNA.
DR   EMBL; CH236959; EAL23788.1; -; Genomic_DNA.
DR   EMBL; BC008743; AAH08743.1; -; mRNA.
DR   EMBL; BC009360; AAH09360.1; -; mRNA.
DR   EMBL; BC010031; AAH10031.1; -; mRNA.
DR   PIR; G02845; G02845.
DR   RefSeq; NP_001010972.1; NM_001010972.1.
DR   RefSeq; NP_003452.1; NM_003461.4.
DR   UniGene; Hs.490415; -.
DR   ProteinModelPortal; Q15942; -.
DR   SMR; Q15942; 382-570.
DR   BioGrid; 113569; 62.
DR   IntAct; Q15942; 40.
DR   MINT; MINT-220515; -.
DR   STRING; 9606.ENSP00000324422; -.
DR   PhosphoSite; Q15942; -.
DR   DMDM; 2497677; -.
DR   OGP; Q15942; -.
DR   MaxQB; Q15942; -.
DR   PaxDb; Q15942; -.
DR   PRIDE; Q15942; -.
DR   DNASU; 7791; -.
DR   Ensembl; ENST00000322764; ENSP00000324422; ENSG00000159840.
DR   GeneID; 7791; -.
DR   KEGG; hsa:7791; -.
DR   UCSC; uc003wcw.3; human.
DR   CTD; 7791; -.
DR   GeneCards; GC07P143078; -.
DR   HGNC; HGNC:13200; ZYX.
DR   HPA; CAB009321; -.
DR   HPA; HPA004835; -.
DR   MIM; 602002; gene.
DR   neXtProt; NX_Q15942; -.
DR   PharmGKB; PA37765; -.
DR   eggNOG; NOG279196; -.
DR   HOGENOM; HOG000220910; -.
DR   HOVERGEN; HBG093602; -.
DR   InParanoid; Q15942; -.
DR   KO; K06273; -.
DR   OMA; APQKKFG; -.
DR   OrthoDB; EOG7992Q6; -.
DR   PhylomeDB; Q15942; -.
DR   TreeFam; TF320310; -.
DR   ChiTaRS; ZYX; human.
DR   GeneWiki; Zyxin; -.
DR   GenomeRNAi; 7791; -.
DR   NextBio; 30155; -.
DR   PMAP-CutDB; Q15942; -.
DR   PRO; PR:Q15942; -.
DR   ArrayExpress; Q15942; -.
DR   Bgee; Q15942; -.
DR   CleanEx; HS_ZYX; -.
DR   Genevestigator; Q15942; -.
DR   GO; GO:0005913; C:cell-cell adherens junction; IDA:MGI.
DR   GO; GO:0005737; C:cytoplasm; IDA:HPA.
DR   GO; GO:0005925; C:focal adhesion; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; TAS:ProtInc.
DR   GO; GO:0001725; C:stress fiber; IDA:UniProtKB.
DR   GO; GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0007155; P:cell adhesion; TAS:ProtInc.
DR   GO; GO:0007267; P:cell-cell signaling; TAS:ProtInc.
DR   GO; GO:0050727; P:regulation of inflammatory response; IEA:Ensembl.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   Gene3D; 2.10.110.10; -; 3.
DR   InterPro; IPR001781; Znf_LIM.
DR   Pfam; PF00412; LIM; 3.
DR   SMART; SM00132; LIM; 3.
DR   PROSITE; PS00478; LIM_DOMAIN_1; 2.
DR   PROSITE; PS50023; LIM_DOMAIN_2; 3.
PE   1: Evidence at protein level;
KW   Acetylation; Cell adhesion; Cell junction; Complete proteome;
KW   Cytoplasm; Cytoskeleton; Direct protein sequencing;
KW   Host-virus interaction; LIM domain; Metal-binding; Nucleus;
KW   Phosphoprotein; Polymorphism; Reference proteome; Repeat; Zinc.
FT   INIT_MET      1      1       Removed.
FT   CHAIN         2    572       Zyxin.
FT                                /FTId=PRO_0000075913.
FT   DOMAIN      384    443       LIM zinc-binding 1.
FT   DOMAIN      444    503       LIM zinc-binding 2.
FT   DOMAIN      504    570       LIM zinc-binding 3.
FT   COMPBIAS     64     77       Pro-rich.
FT   COMPBIAS     94    108       Pro-rich.
FT   COMPBIAS    115    121       Pro-rich.
FT   COMPBIAS    127    137       Pro-rich.
FT   MOD_RES       2      2       N-acetylalanine.
FT   MOD_RES     143    143       Phosphoserine (By similarity).
FT   MOD_RES     169    169       Phosphoserine.
FT   MOD_RES     179    179       Phosphothreonine.
FT   MOD_RES     259    259       Phosphoserine.
FT   MOD_RES     265    265       N6-acetyllysine (By similarity).
FT   MOD_RES     267    267       Phosphoserine.
FT   MOD_RES     270    270       Phosphothreonine.
FT   MOD_RES     272    272       N6-acetyllysine (By similarity).
FT   MOD_RES     274    274       Phosphothreonine.
FT   MOD_RES     279    279       N6-acetyllysine.
FT   MOD_RES     281    281       Phosphoserine.
FT   MOD_RES     288    288       Phosphoserine.
FT   MOD_RES     308    308       Phosphoserine.
FT   MOD_RES     344    344       Phosphoserine.
FT   VARIANT     223    223       H -> L (in dbSNP:rs11978404).
FT                                /FTId=VAR_034081.
FT   MUTAGEN      71     71       F->A: Reduced interaction with ENAH and
FT                                VASP.
FT   MUTAGEN      93     93       F->A: Reduced interaction with ENAH and
FT                                VASP.
FT   MUTAGEN     104    104       F->A: Greatly reduced interaction with
FT                                ENAH and VASP; when associated with A-71
FT                                or with A-71 and A-93.
FT   MUTAGEN     114    114       F->A: No targeting to focal adhesions and
FT                                reduced actin-rich structures; when
FT                                associated with A-71; A-93 and A-104.
SQ   SEQUENCE   572 AA;  61277 MW;  2833B1EFA260B762 CRC64;
     MAAPRPSPAI SVSVSAPAFY APQKKFGPVV APKPKVNPFR PGDSEPPPAP GAQRAQMGRV
     GEIPPPPPED FPLPPPPLAG DGDDAEGALG GAFPPPPPPI EESFPPAPLE EEIFPSPPPP
     PEEEGGPEAP IPPPPQPREK VSSIDLEIDS LSSLLDDMTK NDPFKARVSS GYVPPPVATP
     FSSKSSTKPA AGGTAPLPPW KSPSSSQPLP QVPAPAQSQT QFHVQPQPQP KPQVQLHVQS
     QTQPVSLANT QPRGPPASSP APAPKFSPVT PKFTPVASKF SPGAPGGSGS QPNQKLGHPE
     ALSAGTGSPQ PPSFTYAQQR EKPRVQEKQH PVPPPAQNQN QVRSPGAPGP LTLKEVEELE
     QLTQQLMQDM EHPQRQNVAV NELCGRCHQP LARAQPAVRA LGQLFHIACF TCHQCAQQLQ
     GQQFYSLEGA PYCEGCYTDT LEKCNTCGEP ITDRMLRATG KAYHPHCFTC VVCARPLEGT
     SFIVDQANRP HCVPDYHKQY APRCSVCSEP IMPEPGRDET VRVVALDKNF HMKCYKCEDC
     GKPLSIEADD NGCFPLDGHV LCRKCHTARA QT
//
ID   ZZEF1_HUMAN             Reviewed;        2961 AA.
AC   O43149; A7MBM5; Q6NXG0; Q6ZRA1; Q6ZSF4; Q9NVB9;
DT   29-MAY-2007, integrated into UniProtKB/Swiss-Prot.
DT   05-MAY-2009, sequence version 6.
DT   14-MAY-2014, entry version 103.
DE   RecName: Full=Zinc finger ZZ-type and EF-hand domain-containing protein 1;
GN   Name=ZZEF1; Synonyms=KIAA0399;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANTS
RP   PRO-1972; VAL-2014 AND GLN-2369.
RC   TISSUE=Brain;
RX   PubMed=9455477; DOI=10.1093/dnares/4.5.307;
RA   Ishikawa K., Nagase T., Nakajima D., Seki N., Ohira M., Miyajima N.,
RA   Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. VIII.
RT   78 new cDNA clones from brain which code for large proteins in
RT   vitro.";
RL   DNA Res. 4:307-313(1997).
RN   [2]
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 1614-2961 (ISOFORM 2), AND VARIANT
RP   ALA-30.
RC   TISSUE=Teratocarcinoma, and Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANTS
RP   PRO-1972; VAL-2014 AND GLN-2369.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   TISSUE SPECIFICITY.
RX   PubMed=15519529; DOI=10.1016/j.ejca.2004.08.005;
RA   Cvekl A. Jr., Zavadil J., Birshtein B.K., Grotzer M.A., Cvekl A.;
RT   "Analysis of transcripts from 17p13.3 in medulloblastoma suggests
RT   ROX/MNT as a potential tumour suppressor gene.";
RL   Eur. J. Cancer 40:2525-2532(2004).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1509 AND SER-1518, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1509 AND SER-1518, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1475, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-2667, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [12]
RP   MYRISTOYLATION AT GLY-2.
RX   PubMed=20213681; DOI=10.1002/pmic.200900783;
RA   Suzuki T., Moriya K., Nagatoshi K., Ota Y., Ezure T., Ando E.,
RA   Tsunasawa S., Utsumi T.;
RT   "Strategy for comprehensive identification of human N-myristoylated
RT   proteins using an insect cell-free protein synthesis system.";
RL   Proteomics 10:1780-1793(2010).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=O43149-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O43149-2; Sequence=VSP_042268, VSP_042269, VSP_042270;
CC         Note=Incomplete sequence. No experimental confirmation
CC         available;
CC       Name=3;
CC         IsoId=O43149-3; Sequence=VSP_036989, VSP_025870, VSP_025871;
CC         Note=May be due to an intron retention. No experimental
CC         confirmation available;
CC   -!- TISSUE SPECIFICITY: Expressed at low levels in cerebellum.
CC   -!- SIMILARITY: Contains 1 DOC domain.
CC   -!- SIMILARITY: Contains 1 EF-hand domain.
CC   -!- SIMILARITY: Contains 2 ZZ-type zinc fingers.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA23695.4; Type=Erroneous initiation; Note=Translation N-terminally shortened;
CC       Sequence=BAA91834.1; Type=Erroneous initiation; Note=Translation N-terminally extended;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB007859; BAA23695.4; ALT_INIT; mRNA.
DR   EMBL; AK001683; BAA91834.1; ALT_INIT; mRNA.
DR   EMBL; AK127482; BAC86999.1; -; mRNA.
DR   EMBL; AC067815; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC087292; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC067099; AAH67099.1; -; mRNA.
DR   EMBL; BC151836; AAI51837.1; -; mRNA.
DR   PIR; T00048; T00048.
DR   RefSeq; NP_055928.3; NM_015113.3. [O43149-1]
DR   UniGene; Hs.277624; -.
DR   ProteinModelPortal; O43149; -.
DR   SMR; O43149; 239-380, 1780-1863.
DR   BioGrid; 116757; 12.
DR   IntAct; O43149; 5.
DR   MINT; MINT-1191246; -.
DR   PhosphoSite; O43149; -.
DR   MaxQB; O43149; -.
DR   PaxDb; O43149; -.
DR   PRIDE; O43149; -.
DR   Ensembl; ENST00000381638; ENSP00000371051; ENSG00000074755. [O43149-1]
DR   GeneID; 23140; -.
DR   KEGG; hsa:23140; -.
DR   UCSC; uc002fxe.3; human. [O43149-1]
DR   UCSC; uc002fxh.3; human. [O43149-2]
DR   UCSC; uc002fxk.1; human. [O43149-3]
DR   CTD; 23140; -.
DR   GeneCards; GC17M003854; -.
DR   H-InvDB; HIX0017584; -.
DR   HGNC; HGNC:29027; ZZEF1.
DR   HPA; HPA031778; -.
DR   HPA; HPA031790; -.
DR   neXtProt; NX_O43149; -.
DR   PharmGKB; PA134938508; -.
DR   eggNOG; NOG254031; -.
DR   HOGENOM; HOG000155817; -.
DR   HOVERGEN; HBG108782; -.
DR   InParanoid; O43149; -.
DR   OMA; WMLEMKQ; -.
DR   OrthoDB; EOG76MK7D; -.
DR   PhylomeDB; O43149; -.
DR   TreeFam; TF331572; -.
DR   ChiTaRS; ZZEF1; human.
DR   GenomeRNAi; 23140; -.
DR   NextBio; 44414; -.
DR   PRO; PR:O43149; -.
DR   ArrayExpress; O43149; -.
DR   Bgee; O43149; -.
DR   CleanEx; HS_ZZEF1; -.
DR   Genevestigator; O43149; -.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   Gene3D; 1.10.238.10; -; 1.
DR   Gene3D; 2.60.120.260; -; 1.
DR   Gene3D; 2.60.120.290; -; 1.
DR   InterPro; IPR004939; APC_su10/DOC_dom.
DR   InterPro; IPR000859; CUB_dom.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR008979; Galactose-bd-like.
DR   InterPro; IPR000433; Znf_ZZ.
DR   Pfam; PF03256; APC10; 1.
DR   Pfam; PF00569; ZZ; 2.
DR   SMART; SM00291; ZnF_ZZ; 2.
DR   SUPFAM; SSF49785; SSF49785; 1.
DR   PROSITE; PS51284; DOC; 1.
DR   PROSITE; PS50222; EF_HAND_2; 1.
DR   PROSITE; PS01357; ZF_ZZ_1; 1.
DR   PROSITE; PS50135; ZF_ZZ_2; 2.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Complete proteome; Lipoprotein;
KW   Metal-binding; Myristate; Phosphoprotein; Polymorphism;
KW   Reference proteome; Repeat; Zinc; Zinc-finger.
FT   INIT_MET      1      1       Removed.
FT   CHAIN         2   2961       Zinc finger ZZ-type and EF-hand domain-
FT                                containing protein 1.
FT                                /FTId=PRO_0000289000.
FT   DOMAIN      111    146       EF-hand.
FT   DOMAIN      226    405       DOC.
FT   ZN_FING    1777   1825       ZZ-type 1.
FT   ZN_FING    1826   1872       ZZ-type 2.
FT   MOD_RES    1475   1475       Phosphoserine.
FT   MOD_RES    1509   1509       Phosphoserine.
FT   MOD_RES    1518   1518       Phosphoserine.
FT   MOD_RES    1540   1540       Phosphoserine (By similarity).
FT   MOD_RES    2667   2667       N6-acetyllysine.
FT   LIPID         2      2       N-myristoyl glycine.
FT   VAR_SEQ       1   1613       Missing (in isoform 2).
FT                                /FTId=VSP_042268.
FT   VAR_SEQ     882    882       M -> MK (in isoform 3).
FT                                /FTId=VSP_036989.
FT   VAR_SEQ    1079   1084       LDVETW -> VTRVST (in isoform 3).
FT                                /FTId=VSP_025870.
FT   VAR_SEQ    1085   2961       Missing (in isoform 3).
FT                                /FTId=VSP_025871.
FT   VAR_SEQ    2405   2424       ILSIMLYSSKKEINALAEHG -> VRDERDSCSSFLVQMCW
FT                                PRS (in isoform 2).
FT                                /FTId=VSP_042269.
FT   VAR_SEQ    2425   2961       Missing (in isoform 2).
FT                                /FTId=VSP_042270.
FT   VARIANT      30     30       V -> A (in dbSNP:rs1454121).
FT                                /FTId=VAR_032551.
FT   VARIANT    1021   1021       I -> V (in dbSNP:rs16953687).
FT                                /FTId=VAR_032552.
FT   VARIANT    1437   1437       S -> A (in dbSNP:rs4790555).
FT                                /FTId=VAR_032553.
FT   VARIANT    1972   1972       L -> P (in dbSNP:rs781852).
FT                                /FTId=VAR_032554.
FT   VARIANT    2014   2014       I -> V (in dbSNP:rs781831).
FT                                /FTId=VAR_032555.
FT   VARIANT    2051   2051       P -> S (in dbSNP:rs1006954).
FT                                /FTId=VAR_032556.
FT   VARIANT    2301   2301       Y -> H (in dbSNP:rs34357158).
FT                                /FTId=VAR_032557.
FT   VARIANT    2303   2303       L -> P (in dbSNP:rs35638819).
FT                                /FTId=VAR_032558.
FT   VARIANT    2369   2369       E -> Q (in dbSNP:rs711177).
FT                                /FTId=VAR_032559.
FT   VARIANT    2421   2421       A -> T (in dbSNP:rs781861).
FT                                /FTId=VAR_032560.
FT   CONFLICT    959    959       V -> A (in Ref. 1; BAA23695 and 5;
FT                                AAI51837).
FT   CONFLICT   1929   1929       R -> H (in Ref. 3; BAA91834).
SQ   SEQUENCE   2961 AA;  331075 MW;  0DB2EB72C16BC168 CRC64;
     MGNAPSHSSE DEAAAAGGEG WGPHQDWAAV SGTTPGPGVA APALPPAAAL LEPARLREAA
     AALLPTPPCE SLVSRHRGAL FRWLEERLGR GEESVTLEQF RELLEARGAG CSSEQFEEAF
     AQFDAEGDGT VDAENMLEAL KNSSGANLQG ELSHIIRQLQ ACSLVPGFTD IFSESKEGLD
     IHSSMILRFL HRNRLSSAVM PYPMLEHCNN MCTMRSSVLK ESLDQLVQKE KESPGDLTRS
     PEMDKLKSVA KCYAYIETSS NSADIDKMTN GETSSYWQSD GSACSHWIRL KMKPDVVLRH
     LSIAVAATDQ SYMPQQVTVA VGRNASDLQE VRDVHIPSNV TGYVTLLENA NVSQLYVQIN
     IKRCLSDGCD TRIHGLRAVG FQRVKKSGVS VSDASAIWYW SLLTSLVTAS METNPAFVQT
     VLHNTQKALR HMPPLSLSPG STDFSTFLSP NVLEEVDSFL IRITSCCSTP EVELTLLAFA
     LARGSVAKVM SSLCTITDHL DTQYDASSLI LSMASVRQNL LLKYGKPLQL TLQACDVKGK
     EDKSGPENLL VEPWTRDGFL TETGKTRAST IFSTGTESAF QVTQIRIMVR RGGIGAQCGL
     VFAYNSSSDK FCAEEHFKRF EKYDKWKLQE LRQFVKSRIG CSSDDLGEDD PIGWFELEEE
     WDEADVKLQQ CRVAKYLMVK FLCTRQESAE RLGVQGLTIS GYLRPARAEA EQSVTCAHCR
     KDTEESVCGA TLLLRTLQFI QQLAHDLVQQ KESGLKYKSF LDFAGLDLQI FWNFYSKLKQ
     NPREECVSAQ TLLLQLLQSC FSVLQGDVLA ASEEEKAPIQ SPKGVEAAKE LYTHLCDVVD
     KVDGDSVPME ILKQEVRNTL LNGAAIFFPN RQTRRNHLFT MMNVTEQEHK QSLQLTFRSL
     CTYFSDKDPG GLLLLPEKND LAKMNISEVL AVMDTLVSVA ARECELLMLS GAPGEVGSVL
     FSLFWSVQGS LLSWCYLQLK STDSGAKDLA VDLIEKYVGQ FLASMRAILE SLFSQYSGKT
     IVERLCNSVF SMAARQLVIF LLDFCTLDIP HCVLLREFSV LTELLKKLCS GPEGGLRKLD
     VETWQQEQPV VLHTWTKESA HNYENNCHEV SVFVSPGATY FEVEFDDRCE TEKRYDYLEF
     TDARGRKTRY DTKVGTDKWP KKVTFKAGPR LQFLFHSDSS HNEWGYKFTV TACGLPDVAV
     SWGLDLQLLV SRLMGRLASQ CMALKSVRQL GSNMVVPQAK MALVLSSPLW KPVFRHQVCP
     ELELEASWPT HPHRNSKEVK NIPDDPCRHF LLDFAQSEPA QNFCGPYSEL FKGFIQACRK
     QAPKTDIVAG STIDQAVNAT FAALVYRTPD LYEKLQKYVN SGGKIALSEE FAQVYSLADG
     IRIWMLEMKQ KSLMSLGNEA EEKHSSEATE VNPESLAKEC IEKSLLLLKF LPTGISSKES
     CEKLETADET SHLQPLNKRQ RTSSVVEEHF QASVSPTEAA PPATGDQSPG LGTQPKLPSS
     SGLPAADVSP ATAEEPLSPS TPTRRPPFTR GRLRLLSFRS MEEARLVPTV KEKYPVLKDV
     MDFIKDQSLS HRSVVKVLSL RKAQAQSILE VLKITQHCAE SLGQPHCFHP PFILFLLELL
     TCQKDFTNYF GHLEGCGADL HKEIRDTYYQ LVLFLVKAVK GFSSLNDRSL LPALSCVQTA
     LLHLLDMGWE PNDLAFFVDI QLPDLLMKMS QENISVHDSV ISQWSEEDEL ADAKQNSEWM
     DECQDGMFEA WYEKIAQEDP EKQRKMHMFI ARYCDLLNVD ISCDGCDEIA PWHRYRCLQC
     SDMDLCKTCF LGGVKPEGHG DDHEMVNMEF TCDHCQGLII GRRMNCNVCD DFDLCYGCYA
     AKKYSYGHLP THSITAHPMV TIRISDRQRL IQPYIHNYSW LLFAALALYS AHLASAEDVD
     GEKLDPQTRS SATTLRSQCM QLVGDCLMKA HQGKGLKALA LLGVLPDGDS SLEDQALPVT
     VPTGASEEQL EKKAVQGAEL SEAGNGKRAV HEEIRPVDFK QRNKADKGVS LSKDPSCQTQ
     ISDSPADASP PTGLPDAEDS EVSSQKPIEE KAVTPSPEQV FAECSQKRIL GLLAAMLPPL
     KSGPTVPLID LEHVLPLMFQ VVISNAGHLN ETYHLTLGLL GQLIIRLLPA EVDAAVIKVL
     SAKHNLFAAG DSSIVPDGWK TTHLLFSLGA VCLDSRVGLD WACSMAEILR SLNSAPLWRD
     VIATFTDHCI KQLPFQLKHT NIFTLLVLVG FPQVLCVGTR CVYMDNANEP HNVIILKHFT
     EKNRAVIVDV KTRKRKTVKD YQLVQKGGGQ ECGDSRAQLS QYSQHFAFIA SHLLQSSMDS
     HCPEAVEATW VLSLALKGLY KTLKAHGFEE IRATFLQTDL LKLLVKKCSK GTGFSKTWLL
     RDLEILSIML YSSKKEINAL AEHGDLELDE RGDREEEVER PVSSPGDPEQ KKLDPLEGLD
     EPTRICFLMA HDALNAPLHI LRAIYELQMK KTDYFFLEVQ KRFDGDELTT DERIRSLAQR
     WQPSKSLRLE EQSAKAVDTD MIILPCLSRP ARCDQATAES NPVTQKLISS TESELQQSYA
     KQRRSKSAAL LHKELNCKSK RAVRDYLFRV NEATAVLYAR HVLASLLAEW PSHVPVSEDI
     LELSGPAHMT YILDMFMQLE EKHEWEKILQ KVLQGCREDM LGTMALAACQ FMEEPGMEVQ
     VRESKHPYNN NTNFEDKVHI PGAIYLSIKF DSQCNTEEGC DELAMSSSSD FQQDRHSFSG
     SQQKWKDFEL PGDTLYYRFT SDMSNTEWGY RFTVTAGHLG RFQTGFEILK QMLSEERVVP
     HLPLAKIWEW LVGVACRQTG HQRLKAIHLL LRIVRCCGHS DLCDLALLKP LWQLFTHMEY
     GLFEDVTQPG ILLPLHRALT ELFFVTENRA QELGVLQDYL LALTTDDHLL RCAAQALQNI
     AAISLAINYP NKATRLWNVE C
//
ID   ZZZ3_HUMAN              Reviewed;         903 AA.
AC   Q8IYH5; B7WPC6; Q6N004; Q6N070; Q8IYP0; Q8IYR1; Q8TEK4; Q9Y4U0;
DT   15-MAY-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2003, sequence version 1.
DT   14-MAY-2014, entry version 115.
DE   RecName: Full=ZZ-type zinc finger-containing protein 3;
GN   Name=ZZZ3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 84-903 (ISOFORM 2).
RC   TISSUE=Adipose tissue, Colon endothelium, and Rectum tumor;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3), AND
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 286-903 (ISOFORM 2).
RC   TISSUE=Brain, Lymph, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 161-903 (ISOFORM 4).
RC   TISSUE=Spleen;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-130; SER-131 AND
RP   SER-135, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   FUNCTION, AND IDENTIFICATION IN ATAC COMPLEX.
RX   PubMed=19103755; DOI=10.1128/MCB.01599-08;
RA   Guelman S., Kozuka K., Mao Y., Pham V., Solloway M.J., Wang J., Wu J.,
RA   Lill J.R., Zha J.;
RT   "The double-histone-acetyltransferase complex ATAC is essential for
RT   mammalian development.";
RL   Mol. Cell. Biol. 29:1176-1188(2009).
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-701, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-113, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [11]
RP   STRUCTURE BY NMR OF 807-875 IN COMPLEX WITH ZINC IONS.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the ZZ domain of ZZZ3 protein.";
RL   Submitted (JUN-2006) to the PDB data bank.
RN   [12]
RP   VARIANT [LARGE SCALE ANALYSIS] SER-456.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Component of the ATAC complex, a complex with histone
CC       acetyltransferase activity on histones H3 and H4.
CC   -!- SUBUNIT: Component of the ADA2A-containing complex (ATAC),
CC       composed of CSRP2BP, KAT2A, TADA2L, TADA3L, ZZ3, MBIP, WDR5,
CC       YEATS2, CCDC101 and DR1.
CC   -!- INTERACTION:
CC       P09022:Hoxa1 (xeno); NbExp=3; IntAct=EBI-2795524, EBI-3957603;
CC       Q92830:KAT2A; NbExp=2; IntAct=EBI-2795524, EBI-477622;
CC   -!- SUBCELLULAR LOCATION: Nucleus (By similarity).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q8IYH5-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8IYH5-2; Sequence=VSP_025511;
CC       Name=3;
CC         IsoId=Q8IYH5-3; Sequence=VSP_025509, VSP_025510;
CC         Note=No experimental confirmation available;
CC       Name=4;
CC         IsoId=Q8IYH5-4; Sequence=VSP_025512, VSP_025513;
CC         Note=No experimental confirmation available;
CC   -!- SIMILARITY: Contains 1 HTH myb-type DNA-binding domain.
CC   -!- SIMILARITY: Contains 1 ZZ-type zinc finger.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL080063; CAB45694.1; -; mRNA.
DR   EMBL; BX641001; CAE46004.1; -; mRNA.
DR   EMBL; BX640658; CAE45800.1; -; mRNA.
DR   EMBL; BX640766; CAE45870.1; -; mRNA.
DR   EMBL; AC093575; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471059; EAX06376.1; -; Genomic_DNA.
DR   EMBL; BC035397; AAH35397.1; -; mRNA.
DR   EMBL; BC035079; AAH35079.1; -; mRNA.
DR   EMBL; BC035818; AAH35818.1; -; mRNA.
DR   EMBL; AK074119; BAB84945.1; -; mRNA.
DR   PIR; T12463; T12463.
DR   RefSeq; NP_056349.1; NM_015534.4. [Q8IYH5-1]
DR   RefSeq; XP_005270782.1; XM_005270725.1. [Q8IYH5-1]
DR   RefSeq; XP_005270783.1; XM_005270726.1. [Q8IYH5-1]
DR   RefSeq; XP_005270784.1; XM_005270727.1. [Q8IYH5-2]
DR   RefSeq; XP_005270785.1; XM_005270728.1. [Q8IYH5-3]
DR   RefSeq; XP_005270786.1; XM_005270729.2. [Q8IYH5-3]
DR   UniGene; Hs.480506; -.
DR   PDB; 2FC7; NMR; -; A=807-875.
DR   PDB; 2YUM; NMR; -; A=652-713.
DR   PDBsum; 2FC7; -.
DR   PDBsum; 2YUM; -.
DR   ProteinModelPortal; Q8IYH5; -.
DR   SMR; Q8IYH5; 652-715, 807-875.
DR   BioGrid; 117482; 21.
DR   DIP; DIP-47289N; -.
DR   IntAct; Q8IYH5; 10.
DR   MINT; MINT-7032149; -.
DR   STRING; 9606.ENSP00000359837; -.
DR   PhosphoSite; Q8IYH5; -.
DR   DMDM; 74762495; -.
DR   MaxQB; Q8IYH5; -.
DR   PaxDb; Q8IYH5; -.
DR   PRIDE; Q8IYH5; -.
DR   DNASU; 26009; -.
DR   Ensembl; ENST00000370798; ENSP00000359834; ENSG00000036549. [Q8IYH5-3]
DR   Ensembl; ENST00000370801; ENSP00000359837; ENSG00000036549. [Q8IYH5-1]
DR   GeneID; 26009; -.
DR   KEGG; hsa:26009; -.
DR   UCSC; uc001dhp.3; human. [Q8IYH5-2]
DR   UCSC; uc001dhq.3; human. [Q8IYH5-1]
DR   UCSC; uc001dhr.3; human. [Q8IYH5-3]
DR   CTD; 26009; -.
DR   GeneCards; GC01M078028; -.
DR   HGNC; HGNC:24523; ZZZ3.
DR   HPA; HPA053663; -.
DR   neXtProt; NX_Q8IYH5; -.
DR   PharmGKB; PA134873184; -.
DR   eggNOG; NOG126842; -.
DR   HOVERGEN; HBG062668; -.
DR   InParanoid; Q8IYH5; -.
DR   OMA; QVKLEDH; -.
DR   OrthoDB; EOG7SFHX8; -.
DR   PhylomeDB; Q8IYH5; -.
DR   TreeFam; TF106396; -.
DR   Reactome; REACT_172623; Chromatin organization.
DR   ChiTaRS; ZZZ3; human.
DR   EvolutionaryTrace; Q8IYH5; -.
DR   GeneWiki; ZZZ3; -.
DR   GenomeRNAi; 26009; -.
DR   NextBio; 47745; -.
DR   PRO; PR:Q8IYH5; -.
DR   ArrayExpress; Q8IYH5; -.
DR   Bgee; Q8IYH5; -.
DR   CleanEx; HS_ZZZ3; -.
DR   Genevestigator; Q8IYH5; -.
DR   GO; GO:0005671; C:Ada2/Gcn5/Ada3 transcription activator complex; IEA:Ensembl.
DR   GO; GO:0003682; F:chromatin binding; IEA:InterPro.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0006325; P:chromatin organization; TAS:Reactome.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   Gene3D; 1.10.10.60; -; 1.
DR   InterPro; IPR009057; Homeodomain-like.
DR   InterPro; IPR017930; Myb_dom.
DR   InterPro; IPR001005; SANT/Myb.
DR   InterPro; IPR000433; Znf_ZZ.
DR   Pfam; PF00249; Myb_DNA-binding; 1.
DR   Pfam; PF00569; ZZ; 1.
DR   SMART; SM00717; SANT; 1.
DR   SMART; SM00291; ZnF_ZZ; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS51294; HTH_MYB; 1.
DR   PROSITE; PS01357; ZF_ZZ_1; 1.
DR   PROSITE; PS50135; ZF_ZZ_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   DNA-binding; Metal-binding; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Transcription; Transcription regulation; Zinc;
KW   Zinc-finger.
FT   CHAIN         1    903       ZZ-type zinc finger-containing protein 3.
FT                                /FTId=PRO_0000287495.
FT   DOMAIN      647    707       HTH myb-type.
FT   DNA_BIND    680    703       H-T-H motif (By similarity).
FT   ZN_FING     817    867       ZZ-type.
FT   MOD_RES     113    113       Phosphoserine.
FT   MOD_RES     130    130       Phosphoserine.
FT   MOD_RES     131    131       Phosphoserine.
FT   MOD_RES     135    135       Phosphoserine.
FT   MOD_RES     394    394       N6-acetyllysine (By similarity).
FT   MOD_RES     701    701       N6-acetyllysine.
FT   VAR_SEQ       1    494       Missing (in isoform 3).
FT                                /FTId=VSP_025509.
FT   VAR_SEQ     495    502       VALKHNKD -> MIDLWLYS (in isoform 3).
FT                                /FTId=VSP_025510.
FT   VAR_SEQ     598    598       Missing (in isoform 2).
FT                                /FTId=VSP_025511.
FT   VAR_SEQ     661    683       KKLEQLLIKYPPEEVESRRWQKI -> VINISKSCRLKKTS
FT                                KQLTSESVL (in isoform 4).
FT                                /FTId=VSP_025512.
FT   VAR_SEQ     684    903       Missing (in isoform 4).
FT                                /FTId=VSP_025513.
FT   VARIANT     456    456       P -> S (in a colorectal cancer sample;
FT                                somatic mutation).
FT                                /FTId=VAR_035718.
FT   CONFLICT    596    596       D -> G (in Ref. 4; AAH35079).
FT   CONFLICT    655    655       W -> G (in Ref. 1; CAB45694).
FT   CONFLICT    698    698       R -> Q (in Ref. 4; AAH35079).
FT   CONFLICT    721    721       Y -> C (in Ref. 4; AAH35079).
FT   CONFLICT    807    807       Q -> R (in Ref. 1; CAE45800).
FT   CONFLICT    877    877       T -> A (in Ref. 1; CAE45870).
FT   HELIX       657    669
FT   HELIX       676    687
FT   STRAND      688    690
FT   HELIX       692    703
FT   HELIX       704    706
FT   STRAND      807    809
FT   STRAND      817    820
FT   STRAND      824    826
FT   STRAND      829    833
FT   STRAND      835    841
FT   STRAND      843    845
FT   STRAND      848    850
FT   HELIX       851    853
FT   STRAND      865    867
FT   STRAND      869    872
SQ   SEQUENCE   903 AA;  102023 MW;  16ED137C0A8202EA CRC64;
     MAASRSTRVT RSTVGLNGLD ESFCGRTLRN RSIAHPEEIS SNSQVRSRSP KKRPEPVPIQ
     KGNNNGRTTD LKQQSTRESW VSPRKRGLSS SEKDNIERQA IENCERRQTE PVSPVLKRIK
     RCLRSEAPNS SEEDSPIKSD KESVEQRSTV VDNDADFQGT KRACRCLILD DCEKREIKKV
     NVSEEGPLNS AVVEEITGYL AVNGVDDSDS AVINCDDCQP DGNTKQNSIG SYVLQEKSVA
     ENGDTDTQTS MFLDSRKEDS YIDHKVPCTD SQVQVKLEDH KIVTACLPVE HVNQLTTEPA
     TGPFSETQSS LRDSEEEVDV VGDSSASKEQ CKENTNNELD TSLESMPASG EPEPSPVLDC
     VSAQMMSLSE PQEHRYTLRT SPRRAAPTRG SPTKNSSPYR ENGQFEENNL SPNETNATVS
     DNVSQSPTNP GEISQNEKGI CCDSQNNGSE GVSKPPSEAR LNIGHLPSAK ESASQHITEE
     EDDDPDVYYF ESDHVALKHN KDYQRLLQTI AVLEAQRSQA VQDLESLGRH QREALKNPIG
     FVEKLQKKAD IGLPYPQRVV QLPEIVWDQY THSLGNFERE FKNRKRHTRR VKLVFDKVGL
     PARPKSPLDP KKDGESLSYS MLPLSDGPEG SSSRPQMIRG RLCDDTKPET FNQLWTVEEQ
     KKLEQLLIKY PPEEVESRRW QKIADELGNR TAKQVASRVQ KYFIKLTKAG IPVPGRTPNL
     YIYSKKSSTS RRQHPLNKHL FKPSTFMTSH EPPVYMDEDD DRSCFHSHMN TAVEDASDDE
     SIPIMYRNLP EYKELLQFKK LKKQKLQQMQ AESGFVQHVG FKCDNCGIEP IQGVRWHCQD
     CPPEMSLDFC DSCSDCLHET DIHKEDHQLE PIYRSETFLD RDYCVSQGTS YNYLDPNYFP
     ANR
//